Dr Fidelma Dunne

Professor of Medicine
Consultant Endocrinologist
Associate Director at the Clinical Research Facility, Galway
President of Irish Endocrine Society

Fidelma Dunne is a Professor in Medicine at the School of Medicine and Associate Director of the Clinical Research Facility (CRF) at University of Galway and a Consultant Endocrinologist at Galway University Hospitals group.

She completed undergraduate training at the University of Galway and postgraduate training (scientific and clinical) at University of Birmingham UK. She holds an MD (University College Cork), PhD (University of Birmingham UK), Masters in Medical Education (University of Dundee Scotland), and Masters in Clinical Research (University of Galway).

She was the Foundation Head of the School of Medicine (2009-2013) and executive board member of Irish Medical Council (2013-2021). Professor Dunne is a member of the Diabetes in Pregnancy Study Group (DPSG) of the European Association for the Study of Diabetes (EASD) and is the current President of the International Association Diabetes in Pregnancy Study Groups (IADPSG) 2016-2022. She was a Fulbright scholar for 2014-2015 at Columbia University New York and is an Adjunct Professor at Steno Diabetes Research Centre in Odense, Denmark (2020-2025).

Professor Dunne’s research interest is in the area of pregnancy and diabetes with >240 peer review publications, 10,000 citations, H index of 52 with >22m euro in grant funding.

Her research group are conducting a number of studies as part of the ATLANTIC Diabetes in Pregnancy (DIP) programme including an IMP regulated trial of Metformin in pregnancies complicated by GDM (EMERGE), investigation of a biomarker (CD59) for GDM diagnosis and a 10 year follow up (metabolic and cardiovascular) of women with prior GDM.

In addition, she has been involved in international studies including a multicentre European funded (FP7) trial on prevention of GDM (DALI), CONCEPTT a JDRF funded trial of continuous glucose monitoring (CGMS) in women with Type 1 Diabetes during pregnancy.

More recently she has been the Irish lead for a pan European cohort study examining pregnancy outcomes of women with Type 1 and Type 2 diabetes (EVOLVE) and the EXPECT study examining insulin Degludec in women with Type 1 Diabetes in pregnancy. She is the PI of the recently funded (Health Research Board) All Ireland Collaborative Clinical Trial Network in Diabetes (2021-2026).

Professor Dunne has also been elected to the role of President of Irish Endocrine Society (IES) 2021-2024